Biohaven Pharmaceutical Holding Company Ltd. Stock price
Compare with Peer Group
Is Biohaven Pharmaceutical Holding Company Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,142 stocks worldwide.
Key metrics
Biohaven Pharmaceutical Holding Company Ltd. Stock Analysis
Analyst Opinions
23 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast:
Analyst Opinions
23 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast:
Don't miss a Thing! We will send you all news about Biohaven Pharmaceutical Holding Company Ltd. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Biohaven Pharmaceutical Holding Company Ltd. Stock News
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
| Head office | Virgin Islands, British |
| CEO | Dr. Coric |
| Employees | 274 |
| Founded | 2022 |
| Website | www.biohaven.com |


